Subclinical arterial and cardiac damage in white-coat and masked hypertension

Wiktoria Wojciechowska1, Katarzyna Stolarz-Skrzypek1, Agnieszka Olszanecka1

  • 1a The First Department of Cardiology, Interventional Electrocardiology and Hypertension , Jagiellonian University Medical College , Kraków , Poland ;

Blood Pressure
|March 9, 2016
PubMed

Insights

Masked hypertension (MH) and white-coat hypertension (WCH) show increased arterial stiffness and heart changes compared to sustained normotension. These conditions are prevalent and require medical attention.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Vascular Biology

Background:

  • Masked hypertension (MH) and white-coat hypertension (WCH) are increasingly recognized conditions.
  • Understanding their impact on cardiovascular health is crucial for early intervention.

Purpose of the Study:

  • To compare arterial and echocardiographic parameters in MH and WCH versus sustained normotension and hypertension.
  • To assess the prevalence and cardiovascular involvement in these hypertension subtypes.

Main Methods:

  • Recruited 303 participants for a family-based population study.
  • Utilized ambulatory blood pressure (BP) monitoring and office BP measurements.
  • Assessed central pulse pressure (PP), aortic pulse-wave velocity (PWV), carotid intima-media thickness (IMT), and cardiac function via ultrasonography.

Main Results:

  • Hypertensive subgroups (sustained hypertension, WCH, MH) exhibited higher peripheral and central PP, PWV, IMT, and left ventricular mass index than normotensive individuals.
  • Peripheral PP and PWV remained significant after adjusting for 24-hour BP.
  • WCH and MH groups showed greater arterial and cardiac involvement than normotensive participants.

Conclusions:

  • MH and WCH, defined by strict criteria, are associated with significant arterial and cardiac changes.
  • These conditions are prevalent in the general population and warrant increased clinical awareness.
  • Early detection and management of MH and WCH are essential to prevent cardiovascular complications.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
710
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
552
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K